CIK: 0001039067 · Show all filings
Period: Q4 2023 (← Previous) (Next →)
Filing Date: Feb 2, 2024
Total Value ($000): $82,916 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| DUOL | DUOLINGO INC | 362,314 | $82,191 | 99.1% | $137.73 | +41.2% | CL A COM | 26603R106 |
| — | CARMELL CORPORATION | 103,061 | $393 | 0.5% | $3.60 | — | COM | 142922103 |
| VERA | VERA THERAPEUTICS INC | 16,060 | $247 | 0.3% | $22.12 | -42.6% | CL A | 92337R101 |
| — | NEUBASE THERAPEUTICS INC | 46,970 | $35 | 0.0% | $0.74 | — | COM NEW | 64132K201 |
| — | PREDICTIVE ONCOLOGY INC | 10,358 | $34 | 0.0% | $3.29 | — | COM | 74039M309 |
| IHT | INNSUITES HOSPITALITY TRUST | 10,000 | $17 | 0.0% | $3.13 | -60.0% | SH BEN INT | 457919108 |